XOMA Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.93 |
Market Cap |
$131.91 M |
Shares Outstanding |
8.72 M |
Public Float |
7.76 M |
Address |
2200 Powell Street Emeryville California 94608 United States |
Employees | - |
Website | http://www.xoma.com |
Updated | 07/08/2019 |
XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. |